File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Secondary head and neck cancer in patients with history of hematological malignancy

TitleSecondary head and neck cancer in patients with history of hematological malignancy
Authors
KeywordsGraft-Versus-Host Disease
Head And Neck Cancer
Hematological Malignancies
Hnscc
Second Cancers
Issue Date2013
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/38137
Citation
Head And Neck, 2013, v. 35 n. 5, p. 729-732 How to Cite?
AbstractBackground: Head and neck cancer is a common second cancer in patients with a history of hematological malignancies. The purpose of this study was present the clinical characteristics and treatment outcomes of this group of patients. Methods: A retrospective analysis was conducted of all patients who had a history of hematological malignancy and developed head and neck cancer in a 10-year period. Results: The cohort had 10 patients; median age was 45.8 years. Most patients were nonsmokers and nondrinkers. Seven patients had chronic graft-versus-host disease. The median interval between the completion of treatment of hematological malignancy and the development of head and neck cancers was 8.79 years (range, 2.33-26.83 years). Six patients were alive and disease-free, 3 developed local recurrence, and 3 had metachronous head and neck cancers. Conclusion: The risk factors and etiology of head and neck cancers in patients with hematological malignancy may be different from the ordinary population. © 2012 Wiley Periodicals, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/173023
ISSN
2015 Impact Factor: 2.76
2015 SCImago Journal Rankings: 1.233
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChung, JCKen_US
dc.contributor.authorTsang, RKYen_US
dc.contributor.authorTo, VSHen_US
dc.contributor.authorHo, ACWen_US
dc.contributor.authorChan, JYWen_US
dc.contributor.authorHo, WKen_US
dc.contributor.authorWei, WIen_US
dc.date.accessioned2012-10-30T06:26:36Z-
dc.date.available2012-10-30T06:26:36Z-
dc.date.issued2013en_US
dc.identifier.citationHead And Neck, 2013, v. 35 n. 5, p. 729-732en_US
dc.identifier.issn1043-3074en_US
dc.identifier.urihttp://hdl.handle.net/10722/173023-
dc.description.abstractBackground: Head and neck cancer is a common second cancer in patients with a history of hematological malignancies. The purpose of this study was present the clinical characteristics and treatment outcomes of this group of patients. Methods: A retrospective analysis was conducted of all patients who had a history of hematological malignancy and developed head and neck cancer in a 10-year period. Results: The cohort had 10 patients; median age was 45.8 years. Most patients were nonsmokers and nondrinkers. Seven patients had chronic graft-versus-host disease. The median interval between the completion of treatment of hematological malignancy and the development of head and neck cancers was 8.79 years (range, 2.33-26.83 years). Six patients were alive and disease-free, 3 developed local recurrence, and 3 had metachronous head and neck cancers. Conclusion: The risk factors and etiology of head and neck cancers in patients with hematological malignancy may be different from the ordinary population. © 2012 Wiley Periodicals, Inc.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/38137en_US
dc.relation.ispartofHead and Necken_US
dc.subjectGraft-Versus-Host Diseaseen_US
dc.subjectHead And Neck Canceren_US
dc.subjectHematological Malignanciesen_US
dc.subjectHnsccen_US
dc.subjectSecond Cancersen_US
dc.titleSecondary head and neck cancer in patients with history of hematological malignancyen_US
dc.typeArticleen_US
dc.identifier.emailTsang, RKY: rkytsang@hku.hken_US
dc.identifier.emailTo, VSH: doctorto@hku.hken_US
dc.identifier.emailChan, JYW: jywchan1@hku.hken_US
dc.identifier.emailWei, WI: hrmswwi@hku.hken_US
dc.identifier.authorityTsang, RKY=rp01386en_US
dc.identifier.authorityTo, VSH=rp01385en_US
dc.identifier.authorityChan, JYW=rp01314en_US
dc.identifier.authorityWei, WI=rp00323en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1002/hed.23026en_US
dc.identifier.pmid22585675-
dc.identifier.scopuseid_2-s2.0-84876041175en_US
dc.identifier.hkuros200707-
dc.identifier.isiWOS:000317304000025-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridChung, JCK=22940027200en_US
dc.identifier.scopusauthoridTsang, RKY=7102940058en_US
dc.identifier.scopusauthoridTo, VSH=35957345400en_US
dc.identifier.scopusauthoridHo, ACW=16202695800en_US
dc.identifier.scopusauthoridChan, JYW=27171772200en_US
dc.identifier.scopusauthoridHo, WK=7402968844en_US
dc.identifier.scopusauthoridWei, WI=7403321552en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats